Theravance Biopharma Results Presentation Deck
May 2023, 41 slides
  1. Theravance Biopharma
  2. Related Decks
  3. Results Presentation Decks
first quarter financial results and business update may | Theravance Biopharma
forward looking statements | Theravance Biopharma
agenda | Theravance Biopharma
targets | Theravance Biopharma
progress against targets | Theravance Biopharma
progress against targets | Theravance Biopharma
progress against financial targets | Theravance Biopharma
| Theravance Biopharma
growing net sales and hospital volume | Theravance Biopharma
hospital and community share trends | Theravance Biopharma
continued record high retail new patient starts | Theravance Biopharma
development top line results a cypress last | Theravance Biopharma
experience informed design | Theravance Biopharma
| Theravance Biopharma
investigational once daily for symptomatic neurogenic in multiple system atrophy | Theravance Biopharma
our cypress study is now recruiting peery a a a for patients with | Theravance Biopharma
designed to reduce symptoms in | Theravance Biopharma
effective treatment requires intact peripheral nerves | Theravance Biopharma
increased prevented blood pressure drop and symptoms worsening in | Theravance Biopharma
the unique benefits of treatment | Theravance Biopharma
offering hope to patients with symptomatic | Theravance Biopharma
new era in treating symptoms product positioning | Theravance Biopharma
financial update | Theravance Biopharma
first quarter | Theravance Biopharma
first quarter | Theravance Biopharma
financial highlights | Theravance Biopharma
million capital return program | Theravance Biopharma
financial guidance | Theravance Biopharma
positioned for value creation | Theravance Biopharma
a session | Theravance Biopharma
inhalation solution | Theravance Biopharma
about inhalation solution | Theravance Biopharma
appendix | Theravance Biopharma
patent protection into late | Theravance Biopharma
collaboration agreement revenue | Theravance Biopharma
milestones and royalties | Theravance Biopharma
and royalty deal summary sow | Theravance Biopharma
substantial opportunity for further growth | Theravance Biopharma
offering hope to patients with symptomatic | Theravance Biopharma
shift toward broad symptomatic improvement for patients cypress | Theravance Biopharma
a year of transformation | Theravance Biopharma
See More
Theravance Biopharma
Results Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Biopharma
Royalty
Hospital
Blood
Medicine
Recent decks by Theravance Biopharma
Results
August 2023
Investor Conference
April 2023
Results
February 2023
Investor Conference
November 2022
See all presentations by Theravance Biopharma (5 decks)
Related decks
Genetron
Results
June 2022
MindMed
Investor Presentation
April 2021
Evotec
Investor Presentation
July 2022
Nuwellis
Investor Presentation
August 2023
Absci
Investor Conference
January 2023
AstraZeneca
Results
February 2021
RenovoRx
IPO
August 2021
AstraZeneca
Investor Day
September 2022
Recent decks by Theravance Biopharma
See all presentations (5 decks)
Results
August 2023
Investor Conference
April 2023
Results
February 2023
Investor Conference
November 2022
Genetron
Results
June 2022
MindMed
Investor Presentation
April 2021
Evotec
Investor Presentation
July 2022
Nuwellis
Investor Presentation
August 2023
Absci
Investor Conference
January 2023
AstraZeneca
Results
February 2021
RenovoRx
IPO
August 2021
AstraZeneca
Investor Day
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights